SALES FORECAST: The Swiss pharma giant's third-quarter sales are forecast at 14.89 billion Swiss francs ($17.22 billion), according to a consensus of 11 analysts' estimates compiled by Visible Alpha.
U.S. consumer groups and two large labor unions urged the U.S. Federal Trade Commission on Thursday to block Novo Holdings, ...
In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Sell rating on Roche Holding AG (RHHVF – Research ...
Goldman Sachs first debuted the GRANOLAS acronym - standing for GSK (GSK), Roche, ASML (ASML), Nestle, Novartis (NVS), Novo Nordisk (NVO), L'Oreal, LVMH, AstraZeneca (AZN), SAP (SAP) and Sanofi (SNY) ...
Barclays analyst Emily Field maintained a Hold rating on Roche Holding AG (RHHVF – Research Report) today and set a price target of ...
One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...
PDUFA date, the U.S. FDA has approved Genentech Inc.’s first-line breast cancer treatment Itovebi (inavolisib). Itovebi is to be combined with Pfizer Inc.’s palbociclib (Ibrance) and fulvestrant for ...
Roche Holding AG will add manufacturing capacity in China to serve the country’s growing market, making it the latest ...
If you're like the vast majority of individual investors, you've never heard of Scholar Rock, apitegromab, or the ...
It feels like a curse! However, plenty of Amazon shoppers are in the same boat, and thousands (60,000 to be exact) say the La Roche-Posay Toleriane Double Repair Face Moisturizer is the only thing ...
* Biosimilar clash may push Novartis to sell Roche stake * Novartis has bet on copycats, Roche sticks to originals * Novartis sees biosimilar discount of up to 75 pct By John ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback